NovaBridge Biosciences (NBP) stock
NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 0/30
$0.90+0.08 (+9.83%)
Close on Nov 18, 2026Market cap $104.20MP/E –Yield –
NovaBridge Biosciences profit margin
Profit margin (net margin) is net income as a percentage of revenue.
NovaBridge Biosciences's profit margin for the twelve months ending Dec 31, 2019 was -4839.8%. For fiscal 2023 it was -5302.0%, against -2648.7% the year before. The highest annual figure on record is 30.5% in fiscal 2020.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -5302.0% | −2653.3 |
| FY2021 | Dec 31, 2021 | -2648.7% | −2679.2 |
| FY2020 | Dec 31, 2020 | 30.5% | +4870.4 |
| FY2019 | Dec 31, 2019 | -4839.8% | −4090.8 |
| FY2018 | Dec 31, 2018 | -749.0% | +1831.8 |
| FY2017 | Dec 31, 2017 | -2580.8% | – |
See a number that looks wrong?